New York City, NY, Dec. 27, 2025 (GLOBE NEWSWIRE) — Intro As medical weight loss continues to evolve in 2026, the landscape of GLP-1 therapies has reached a pivotal moment with expanded FDA-recognized access pathways, emerging treatment formats, and enhanced clinical support structures designed to optimize sustainable weight management outcomes. Driven by advancements in semaglutide […]

Best Semaglutide For Weight Loss 2026: Is MEDVi the Best GLP-1 Supplier for a Sustainable Online Weight Loss Program? Best semaglutide for weight loss in 2026 explained. Explore FDA-approved options, GLP-1 programs, safety, access pathways, and MEDVi's structured online weight loss platform. GlobeNewswire December 27, 2025 New York City, NY, Dec. 27, 2025 (GLOBE NEWSWIRE)

NEW YORK CITY, NY / ACCESS Newswire / December 27, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE:INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), of the important January 5, 2026 lead plaintiff

ENCINITAS, Dec. 27, 2025 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only–not medical advice. Always consult a qualified healthcare professional before starting any prescription treatment. NAD+ is a naturally occurring coenzyme; pharmacy-compounded NAD+ injections require individual prescriptions and are not FDA-approved as finished products. A licensed clinician must evaluate you, and prescription

Best NAD+ Injection for 2026: Sprout Health Lists Compounded NAD+ at $149 First Month as Telehealth Longevity Programs Expand Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know Before Choosing a Telehealth NAD+ Provider in 2026 GlobeNewswire December 27, 2025 ENCINITAS, Dec. 27, 2025 (GLOBE NEWSWIRE) — Disclaimer: This article

NEW YORK CITY, NY / ACCESS Newswire / December 27, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE:PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"), of the important January 16, 2026 lead plaintiff deadline. SO

San Diego, California–(Newsfile Corp. – December 27, 2025) – Robbins Geller Rudman & Dowd LLP announces that the F5 class action lawsuit – captioned Smith v. F5, Inc., No. 25-cv-02619 (W.D. Wash.) – seeks to represent purchasers or acquirers of F5, Inc. (NASDAQ: FFIV) securities and charges F5 and certain of F5’s executives with violations

Melbourne, Australia, Dec. 27, 2025 (GLOBE NEWSWIRE) — $LIVEBEAR, a community driven Solana based token built around culture, creativity, and real-world engagement, has officially announced a major milestone with the burn of 215 million $LIVEBEAR tokens, permanently removed from circulation by the development team. This strategic burn reinforces the project's long-term commitment to sustainability, transparency,

$LIVEBEAR: The Chillest Bear on the Internet, Now Going Worldwide After the Recent Token Burn Following the recent token burn, $LIVEBEAR moves into its next chapter with global momentum and an expanding audience. GlobeNewswire December 27, 2025 Melbourne, Australia, Dec. 27, 2025 (GLOBE NEWSWIRE) — $LIVEBEAR, a community driven Solana based token built around culture,

(NYSE:CPNG), NEW YORK, Dec. 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Coupang, Inc. (NYSE: CPNG) between August 6, 2025 and December 16, 2025, both dates inclusive (the “Class Period”), of the important February 17, 2026 lead plaintiff deadline in the securities class